BeyondSpring Inc.

NASDAQ: BYSI · Healthcare · Biotechnology

PublicHQ Florham Park, NYCIK 0001677940Reports USD

#1143 of 1,394 Healthcare companies by revenue

EA Score

34D

FH 32DQ 47GM 8SS 51

v0.1 · 65/100 weight · provisional

↑ return on assets, market scale · ↓ 3-yr revenue growth, Piotroski F

Methodology →

Revenue TTM

Rev growth YoY (TTM)

-100.0%

Net income (FY)

-$1.0M

Employees

Market cap

$76.9M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$0$02025

Net income-$1.0M-$1.0M2025

Operating income-$8.9M-$8.9M2025

Total assets$25.9M$25.9M2025

Liabilities$49.9M$49.9M2025

Equity-$32.2M-$32.2M2025

Revenue trend

FY2018 – FY2025 · USD

FY18

FY19

$180.0k

FY20

$1.4M

FY21

$1.4M

FY22

FY24

FY25

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

BeyondSpring Inc. booked $0 in FY2025 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.

Peers · Healthcare

Sera Prognostics, Inc.44D LENSAR Inc55C Rapid Micro Biosystems, Inc.46D RetinalGenix Technologies Inc.——

Key facts

CEOLan Huang

SectorHealthcare

IndustryBiotechnology

HeadquartersFlorham Park, NY

ExchangeNASDAQ: BYSI

Employees40

IPO date2017-03-09

Latest filings

8-K2026-06-04 10-Q2026-05-13 8-K2026-05-13 10-K2026-03-25 8-K2026-03-25 8-K2025-12-15 8-K2025-11-21 10-Q2025-11-12

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.